Jove
Visualize
Contact Us

Related Experiment Videos

Reimbursement for clinical flow cytometry testing

G T Stelzer1, D L Grimaud

  • 1Cytometry Associates, Incorporated, Brentwood, Tennessee 37027.

Annals of the New York Academy of Sciences
|March 20, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contributions of flow cytometry to the analysis of the myelodysplastic syndrome.

Clinics in laboratory medicine·2002
Same author

U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures.

Cytometry·1997
Same author

Immunologic differentiation of absolute lymphocyte count with an integrated flow cytometric system: a new concept for absolute T cell subset determinations.

Cytometry·1995
Same author

Shear-induced platelet activation measured by flow cytometry.

Annals of the New York Academy of Sciences·1994
Same author

Isolation and characterization of an early T-helper/inducer cell line with a unique pattern of surface phenotype, constitutive cytokine secretion and myc oncogene expression.

Leukemia·1993
Same author

Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis.

American journal of clinical pathology·1993
Same journal

Multiomics Profiling During Autoimmune Demyelination Highlights a Complex Regulatory Role for Ataxin-1 in B Cells.

Annals of the New York Academy of Sciences·2026
Same journal

Global Trends in Light Pollution and Their Relationship With Socioeconomic Factors.

Annals of the New York Academy of Sciences·2026
Same journal

Wired for Corruption: Inter-Brain Synchrony Encodes Bribery-Related Value Information and Predicts Bribery Agreement.

Annals of the New York Academy of Sciences·2026
Same journal

LM-YOLO: A Lightweight Multi-Scale Enhanced Model for Forest Smoke Detection Using Unmanned Aerial Vehicles.

Annals of the New York Academy of Sciences·2026
Same journal

Polyrhythm Perception and Production: A Scoping Review.

Annals of the New York Academy of Sciences·2026
Same journal

DARTS-CNN-BiLSTM: Intelligent Fault Diagnosis for Computer Numerical Control Machine Tool Feed System.

Annals of the New York Academy of Sciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Understanding reimbursement for new laboratory technology, like flow cytometry, is crucial for providers. Correct billing and educating healthcare carriers are key to securing fair payment for advanced diagnostic tests.

Area of Science:

  • Clinical diagnostics
  • Health economics
  • Laboratory medicine

Background:

  • Reimbursement for novel laboratory technologies remains poorly understood by healthcare providers across the US.
  • The current healthcare funding environment necessitates a clear understanding of payment structures for new medical innovations.
  • Flow cytometry testing reimbursement faces specific challenges, with some carriers incorrectly classifying it as investigational.

Purpose of the Study:

  • To elucidate the complexities of reimbursement for new laboratory technologies, focusing on flow cytometry.
  • To provide guidance for clinicians and laboratory personnel navigating payment challenges with healthcare carriers.
  • To emphasize the importance of accurate billing and carrier education for securing appropriate reimbursement.

Main Methods:

Related Experiment Videos

  • Analysis of current reimbursement practices and challenges for laboratory testing.
  • Review of regulatory guidelines, including the 1988 HCFA ruling on flow cytometry.
  • Case study approach involving provider-carrier interactions and claim adjudication processes.

Main Results:

  • Many state Medicare carriers incorrectly list flow cytometry as investigational, despite federal rulings.
  • Providers must actively educate carriers about the medical necessity and appropriate use of new technologies.
  • Correct billing with approved ICD-9-CM and CPT-4 codes is essential for claim approval.

Conclusions:

  • Establishing a strong working relationship with local Medicare carriers is critical for fair reimbursement.
  • Providers must be prepared to justify the cost and medical necessity of new laboratory tests, including flow cytometry.
  • Proactive education and diligent claims management are vital for overcoming reimbursement barriers in laboratory medicine.